| Mallory Reeves, DO | |
|
1606 Mcarthur St, Manchester, TN 37355-2522 | |
| (931) 723-2036 | |
| Not Available |
| Full Name | Mallory Reeves |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1606 Mcarthur St, Manchester, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912388687 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 3132 (Tennessee) | Secondary |
| 208000000X | Pediatrics | 3132 (Tennessee) | Primary |
| Entity Name | Amg-southern Tennessee Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164789467 PECOS PAC ID: 5991765943 Enrollment ID: O20041013001206 |
News Archive
"[T]he White House team is retooling its message and strategy, hoping a more modest approach will reinvigorate Obama's signature domestic policy initiative and give him a first-year victory for Democrats to carry into the 2010 midterm elections," the Washington Post reports.
Horizon Pharma, Inc. announced today that it has filed a registration statement on form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by the Company.
Sprint and Calgary Scientific have partnered to market a first of its kind medical imaging solution that could contribute to better patient outcomes, faster treatment decisions and a reduced financial burden on long-term patient care.
A research team at the Umea Center for Molecular Medicine (UCMM) in Sweden, led by Professor Leif Carlsson, has managed to specifically establish and isolate the tissue-specific stem cell that produces blood cells (blood stem cell) by using genetically modified embryonic stem cells.
Levels of certain blood proteins indicate which diabetes patients will likely develop life-threatening kidney problems in the future, according to two studies appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mallory Reeves, DO 1606 Mcarthur St, Manchester, TN 37355-2522 Ph: (931) 723-2036 | Mallory Reeves, DO 1606 Mcarthur St, Manchester, TN 37355-2522 Ph: (931) 723-2036 |
News Archive
"[T]he White House team is retooling its message and strategy, hoping a more modest approach will reinvigorate Obama's signature domestic policy initiative and give him a first-year victory for Democrats to carry into the 2010 midterm elections," the Washington Post reports.
Horizon Pharma, Inc. announced today that it has filed a registration statement on form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by the Company.
Sprint and Calgary Scientific have partnered to market a first of its kind medical imaging solution that could contribute to better patient outcomes, faster treatment decisions and a reduced financial burden on long-term patient care.
A research team at the Umea Center for Molecular Medicine (UCMM) in Sweden, led by Professor Leif Carlsson, has managed to specifically establish and isolate the tissue-specific stem cell that produces blood cells (blood stem cell) by using genetically modified embryonic stem cells.
Levels of certain blood proteins indicate which diabetes patients will likely develop life-threatening kidney problems in the future, according to two studies appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 6 days ago